FGFs in CKD
<p dir="ltr">In the present work we have measured plasma concentrations of FGF19, 21 and 23 in a large group of patients with CKD and ESKD and control subjects, as well as identifying clinically relevant genetic variants and tag-SNPs. By combining these genetic and nongenetic data wi...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Publié: |
2025
|
| Sujets: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| Résumé: | <p dir="ltr">In the present work we have measured plasma concentrations of FGF19, 21 and 23 in a large group of patients with CKD and ESKD and control subjects, as well as identifying clinically relevant genetic variants and tag-SNPs. By combining these genetic and nongenetic data with other clinical and demographic features, we aimed to build models able to predict the occurrence of CVE in CKD patients.</p> |
|---|